Extra medicines with light therapy for newborn jaundice
Part of Genetic & congenital clinical trials.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn babies of any gender
- Born at 32 weeks of pregnancy or later
- Able to take feedings by mouth or tube
- Diagnosed with jaundice that is not caused by red blood cell breakdown
- Need light therapy within the first week of life
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
This study tests whether gentle foot reflexology and massage can help newborns with jaundice (high bilirubin levels in the blood) recover faster during light therapy treatment. Jaundice is common in newborns and is usually treated with special lights; this trial explores whether touch therapy might improve outcomes.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
This trial tests a scoring tool called BIND to see how well it predicts which newborns with severe jaundice need intensive treatment. If you have a baby under 28 days old with severe jaundice that might need a blood transfusion, this study could apply to them.
This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.